Loading
Life sciences · Journal article
Journal of Food Bioactives · October 9, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Pyroglutamyl-leucine (pyroGlu-Leu) is a food-derived modified peptide known to modulate the gut microbiota. This study examined the effects of orally administered rice protein hydrolysate (RPH) containing pyroGlu-Leu in rats fed a 45% high-fat diet that induced mild dysbiosis without obesity or severe liver dysfunction. In addition to short-chain fatty acids (SCFAs), several N-acetyl amino acids (NAAAs) were detected in cecal contents. The high-fat diet significantly decreased both SCFAs and NAAAs, whereas administration of RPH or synthetic pyroGlu-Leu restored the levels of NAAAs despite not recovering those of SCFAs. RPH did not alter the overall gut microbial composition but modified specific bacterial taxa that correlated with NAAA levels. These results suggest that NAAAs are gut microbiota-derived metabolites that respond more sensitively to food-derived modulation of the gut microbiota than SCFAs, and may serve as early indicators of microbiota–host metabolic interactions.